| Diagnostic and risk criteria for HSCT-associated thrombotic microangiopathy: a study in children and young adults S Jodele, SM Davies, A Lane, J Khoury, C Dandoy, J Goebel, K Myers, ... Blood, The Journal of the American Society of Hematology 124 (4), 645-653, 2014 | 372 | 2014 |
| A new paradigm: diagnosis and management of HSCT-associated thrombotic microangiopathy as multi-system endothelial injury S Jodele, BL Laskin, CE Dandoy, KC Myers, J El-Bietar, SM Davies, ... Blood reviews 29 (3), 191-204, 2015 | 325 | 2015 |
| On-chip recapitulation of clinical bone marrow toxicities and patient-specific pathophysiology DB Chou, V Frismantas, Y Milton, R David, P Pop-Damkov, D Ferguson, ... Nature biomedical engineering 4 (4), 394-406, 2020 | 210 | 2020 |
| The genetic fingerprint of susceptibility for transplant-associated thrombotic microangiopathy S Jodele, K Zhang, F Zou, B Laskin, CE Dandoy, KC Myers, A Lane, ... Blood, The Journal of the American Society of Hematology 127 (8), 989-996, 2016 | 172 | 2016 |
| Complement blockade for TA-TMA: lessons learned from a large pediatric cohort treated with eculizumab S Jodele, CE Dandoy, A Lane, BL Laskin, A Teusink-Cross, KC Myers, ... Blood 135 (13), 1049-1057, 2020 | 171 | 2020 |
| Mutations in signal recognition particle SRP54 cause syndromic neutropenia with Shwachman-Diamond–like features R Carapito, M Konantz, C Paillard, Z Miao, A Pichot, MS Leduc, Y Yang, ... The Journal of clinical investigation 127 (11), 4090-4103, 2017 | 153 | 2017 |
| Variable eculizumab clearance requires pharmacodynamic monitoring to optimize therapy for thrombotic microangiopathy after hematopoietic stem cell transplantation S Jodele, T Fukuda, K Mizuno, AA Vinks, BL Laskin, J Goebel, BP Dixon, ... Biology of blood and marrow transplantation 22 (2), 307-315, 2016 | 149 | 2016 |
| Variable clinical presentation of Shwachman–Diamond syndrome: update from the North American Shwachman–Diamond syndrome registry KC Myers, AA Bolyard, B Otto, TE Wong, AT Jones, RE Harris, SM Davies, ... The Journal of pediatrics 164 (4), 866-870, 2014 | 148 | 2014 |
| New approaches in the diagnosis, pathophysiology, and treatment of pediatric hematopoietic stem cell transplantation-associated thrombotic microangiopathy S Jodele, CE Dandoy, KC Myers, J El-Bietar, A Nelson, G Wallace, ... Transfusion and Apheresis Science 54 (2), 181-190, 2016 | 115 | 2016 |
| Clinical and molecular pathophysiology of Shwachman–Diamond syndrome: an update KC Myers, SM Davies, A Shimamura Hematology/Oncology Clinics 27 (1), 117-128, 2013 | 115 | 2013 |
| Hematopoietic stem cell transplantation for bone marrow failure syndromes in children KC Myers, SM Davies Biology of Blood and Marrow Transplantation 15 (3), 279-292, 2009 | 114 | 2009 |
| Ruxolitinib as salvage therapy in steroid-refractory acute graft-versus-host disease in pediatric hematopoietic stem cell transplant patients P Khandelwal, A Teusink-Cross, SM Davies, AS Nelson, CE Dandoy, ... Biology of Blood and Marrow Transplantation 23 (7), 1122-1127, 2017 | 107 | 2017 |
| Distinct genetic pathways define pre-malignant versus compensatory clonal hematopoiesis in Shwachman-Diamond syndrome AL Kennedy, KC Myers, J Bowman, CJ Gibson, ND Camarda, E Furutani, ... Nature communications 12 (1), 1334, 2021 | 104 | 2021 |
| Somatic mutations and clonal hematopoiesis in congenital neutropenia J Xia, CA Miller, J Baty, A Ramesh, MRM Jotte, RS Fulton, TP Vogel, ... Blood, The Journal of the American Society of Hematology 131 (4), 408-416, 2018 | 102 | 2018 |
| Diagnosis, treatment, and molecular pathology of Shwachman-Diamond syndrome AS Nelson, KC Myers Hematology/Oncology Clinics 32 (4), 687-700, 2018 | 97 | 2018 |
| Clinical features and outcomes of patients with Shwachman-Diamond syndrome and myelodysplastic syndrome or acute myeloid leukaemia: a multicentre, retrospective, cohort study KC Myers, E Furutani, E Weller, B Siegele, A Galvin, V Arsenault, BP Alter, ... The Lancet Haematology 7 (3), e238-e246, 2020 | 87 | 2020 |
| Radiation-free, alternative-donor HCT for Fanconi anemia patients: results from a prospective multi-institutional study PA Mehta, SM Davies, T Leemhuis, K Myers, NA Kernan, SE Prockop, ... Blood, The Journal of the American Society of Hematology 129 (16), 2308-2315, 2017 | 86 | 2017 |
| Pathogenesis of ELANE-mutant severe neutropenia revealed by induced pluripotent stem cells RC Nayak, LR Trump, BJ Aronow, K Myers, P Mehta, T Kalfa, ... The Journal of clinical investigation 125 (8), 3103-3116, 2015 | 85 | 2015 |
| Mouse models of neutropenia reveal progenitor-stage-specific defects DE Muench, A Olsson, K Ferchen, G Pham, RA Serafin, ... Nature 582 (7810), 109-114, 2020 | 84 | 2020 |
| An intermediate alemtuzumab schedule reduces the incidence of mixed chimerism following reduced-intensity conditioning hematopoietic cell transplantation for hemophagocytic … RA Marsh, MO Kim, C Liu, D Bellman, L Hart, M Grimley, A Kumar, ... Biology of Blood and Marrow Transplantation 19 (11), 1625-1631, 2013 | 81 | 2013 |
